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The nucleotide sequence of the region between the 16S and 23S rRNA genes of the facultative 
anaerobic bacterium Gardnerella vaginalis has been determined, together with the 5' proximal 
500 nucleotides of the 23S rRNA gene. Regions suited for the development of specific, probe- 
confirmable polymerase chain reaction (PCR) assays were selected. PCR assays were evaluated 
with respect to sensitivity and specificity, the latter in comparison with a number of G. vaginalis 
reference strains and closely related species like Bifidobacterium spp. In an initial diagnostic study 
it appeared that the PCR test detected G. vaginalis in 40% of women irrespective of their clinical 
status. Ten out of 11 patients suffering from bacterial vaginosis as defined on the basis of clinical 
parameters were carrying G. vaginalis. 
KEYWORDS: Gardnerella vaginalis, polymerase chain reaction, internal transcribed spacer 
region. 
INTRODUCTION 
The three main categories of vaginitis are caused by 
Trichomonas vaginalis, yeast or bacteria. I Bacterial 
vaginosis (BV) by itself accounts for up to 50% of all 
patient cases. 2 It became apparent hat a large number 
of organisms also present in the healthy vaginal flora 
can become predominant during periods of BV. 
Among these are species like Veillonella parvula, 3
Mycoplasma hominis, 4Peptostreptococcus spp.,  s Mo- 
biluncus spp. 6 and Gardnerella vaginalis. 7 Most of 
these organisms have also been implicated as po- 
tential causes of BV sequelae like pelvic inflammatory 
disease, 8 postpartum endometritis 9and urinary tract 
infection. I° 
Gardnerella vaginalis is an interesting member of 
the array of BV-related organisms. An extensive num- 
ber of microbiological, biochemical and molecular 
studies has been performed in order to gain insight 
in the organisms' classification and life cycle. 3'u G. 
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vaginalis still is the sole species in the genus and 
immunochemical detection and identification was 
described by several authors. 12'13 G. vaginalis-specific 
DNA segments appeared to be useful for species 
determination 14"1s and a DNA probe specific for G. 
vaginalis rRNA was developed. 16 
In this study we developed a G. vaginalis-specific 
polymerase chain reaction (PCR), which could be 
used for species identification and detection. The 
nucleotide sequence of the internal transcribed spacer 
region as present between 16S and 23S rRNA genes 
and the 5" part of the 23S rRNA gene were determined. 
Based on these sequences several PCR assays were 
designed and evaluated. 
MATERIALS AND METHODS 
Bacterial strains and DNA purification 
Table 1 surveys the bacterial strains that were obtained 
from clinical practice or the ATCC, CCUG or LMG 
culture collections and were grown on agar-based 
media before DNA extraction. Two subcultures of the 
type strain of G. vaginalis (CCUG 3717 T and ATCC 
14018 T) were included. Reference strains were char- 
acterized by means of cellular fatty acid analysis 17 and 
the rapid ID32 strep Microtest (BioMerieux, France) 
/Falsen, van Esbroeck and Goossens, unpublished 
data). G. vaginalis 2887/10 through 9895/24 are clin- 
ical isolates (see Table 1). These isolates were char- 
acterised on the basis of colony morphology and a 
negative catalase test. Special attention was given to 
Bifidobacterium species since 16S rRNA sequence 
analysis revealed a close relatedness between Bifido- 
bacteria and G. vaginalis. 18 Cells were harvested in 
phosphate buffered saline (PBS) pH 7.0 and DNA 
was isolated and purified by subsequent proteinase 
K digestion (1 mg m1-1 proteinase K in 10 mM Tris- 
HCI pH 8-0, 1 mM EDTA, 1% SDS for 1 h at 37°C) 
and phenol extractions. After the extractions DNA 
was precipitated using ethanol and the resulting pellet 
was dissolved in distilled water. The DNA con- 
centrations of the final solutions was determined 
spectrophotometrically and was adjusted to 
10 ng ILl -1. DNA solutions were stored at -20°C. 
PCR amplification 
PCRs were performed in Biomed model 60 thermo- 
cyclers. The reaction mixtures (100 ill) consisted of 
60 mM Tris-HCI pH 9.0, 2.5 mM MgCI2, 50 mM KCl, 
0.01% Triton X-100, 0.2 mM desoxyribonucleotide 
triphosphates, 0.25 U Tth.DNA polymerase (Sphaero 
Q, Leiden, The Netherlands) and 50 pmol of both 
sense and antisense primers. The PCR programme 
consisted of a 2-min predenaturation step at 94°C. 
Cycling involved 40 times 1 min 94°C, 1 rain 50°C 
and 1 min 74°C. Reaction products were analysed by 
electrophoresis through 1-3% agarose gels in 40 mM 
Tris-acetate pH 7-8, 2 mM EDTA, followed by ethi- 
dium-bromide staining and Polaroid photography. 
Amplification and sequence determination of 
the ribosomal intergenic spacer region 
In order to determine the internal transcribed spacer 
(ITS) DNA sequence for G. vaginalis, DNA from G. 
vaginalis ATCC 14018 T was PCR amplified using 16S 
and 23S ribosomal consensus primers (primers //3 
and the complement of//519). One of the primers was 
equipped with a biotin moiety at its 5' end. After 
PCR, the biotinylated DNA fragment (approximately 
870 bp in length) was bound to Streptavidin-coated 
magnetic beads (Dynabeads M280, Dynal AS, Oslo, 
Norway). These beads were subsequently treated with 
alkali (0-2 M NaOH) and the water phase was neut- 
ralized by addition of equimolar amounts of hydro- 
chloric acid and 1/10 volume 1M Tris-HCI pH 8-0. 
Both the DNA coupled to and eluted from the beads 
was subjected to manual dideoxy sequencing ac- 
cording to Sanger (T7 sequencing kit, Pharmacia, the 
Netherlands). aSS-labelled dATP (Amersham, UK) was 
used for radioactive labelling of the reaction products. 
Sequence determination was performed by use of the 
PCR primers and sequencing primers A through F 
(Table 2). 
Selection and evaluation of G. vaginalis 
specific PCR primers and probes 
The G. vaginalis ITS sequence was compared to 
similar sequences as determined for Streptococcus 
pneumoniae, Anacystis nidulans, Escherichia coli, 
Rhodobacter sphaeroides, Mycobacterium leprae and 
Streptomyces griseus using PC gene software and the 
Genbank sequence depository (Genbank, National 
Center for Biotechnology Information, Bethesda, 
USA). Comparisons among this phylogenetically di- 
verse set of prokaryotes led to the determination of 
various hypervariable DNA sequence loci. Species- 
specific oligonucleotides (D and G through K) de- 
duced from these regions are indicated in Table 2. 
Various PCR tests, enabled by the selection of the 
most variable domains, were performed. The bacteria 
mentioned in Table 1 were used as a reference panel. 
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Bacterial species PCR G/J H/K 
probe H 
G/K 























Lactobacillus acido ~hilus 
Lactobacillus acido ~hilus 
Lactobacillus acido philus 
Lactobacillus acido ~hilus 
Lactobacillus acido ~hilus 
Lactobacillus acido ~hilus 
Lactobacillus acido ~hilus 
Lactobacillus acido ~hilus 
Lactobacillus aciclo ~hilus 








CCUG 3717 T + + + + + + 
CCUG 3990 + + + + + + 
CCUG 4123 + + + + + + 
CCUG 7921 + + + + + + 
CCUG 11278A + + + + + + 
CCUG 28963 + + + + + + 
CCUG 30587 + + + + + + 
CCUG 30841 + + + + + + 
CCUG 7154 + + + + + + 
CCUG 7712 + + + + + + 
ATCC 14018 T + + + + + + 
2887/10 + + + + + + 
3064/17 + + + + + + 
5457/19 + + + + + + 
5391/18 + + + + + + 
4841/9 + + + + + + 
9895/24 + + + + + + 
LMG 13208 . . . . . .  
LMG 13207 . . . . . .  
LMG 11590 . . . . . .  
LMG "13209 . . . . .  + 
LMG 13203 . . . . . .  
01719/8 . . . . . .  
01834 - - - + + + 
01893 - - - + + + 
02028 . . . . . .  
01997 -- -- - __+ -- -- 
01919 -- - -- 4- + + 
260415 . . . . . .  
260418 . . . . . .  
3313116 . . . . . .  
5656119 . . . . . .  
Gardnerella vaginalis 2887/10 to Lactobacillus acidophilus 5658/19 are clinical isolates. For the following organisms the HK PCR in 
combination with DNA probe D was performed: Clostridium perfringens, Helicobacter pylori, Enterobacter agglomerans, Campylobacter 
jejuni, Enterobacter cloacae, Staphylococcus aprophyticus, Klebsiella pneumoniae, Pseudomonas cepacia, Listeria monocytogenes, 
Citrobacter freundii, Proteus vulgaris, Pseudomonas aeruginosa, Bacillus fragilis, Salmonella serovar godesberg, Haemophilus influenzae, 
5almonella serovar senftenberg, Moraxella catarrhalis, 5higella flexneri, Staphylococcus aureus, Bordetella pertussis, Streptococcus 
agalactiae, Enterococcus faecalis, Cryptococcus neoformans, 5taphylococcus epidermidis and Candida albicans. 
The PCR conditions were as described above. Amp- 
lified DNA was analysed by electrophoresis and after 
staining with ethidium bromide and Polaroid pho- 
tography, gels were Southern blotted onto Hybond 
N ÷ nylon filters. Subsequently, the amplif ied DNA 
was identified by hybridization with 5'-end-I~belled 
probes. Labelling and hybridization were performed 
by standard methods. 2° Autoradiography was ex- 
ecuted for 3-16 h at -70°C using Kodak X-omat AR 
films. 
Diagnost ic appl icat ion of  the G. vaginalls PCR 
test 
Twelve CCUG strains of G. vaginalis and a single S. 
acidominimus strain of which six displayed abberant 
biochemical profiles or fatty acid profiles were ana- 
lysed bl indly by the PCR in order to reconfirm the 
species nature (see Table 3). PCR was performed 
using primers H and K and amplif ied DNA was probed 
with primer D. 
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Table 2. Survey of oligonucleotides used for sequencing and amplification of the G. vaginalis internal transcribed 
spacer region 
Primer code Aim Polarity Position Nucleotide sequence 
A S + 512-531 (23S) 
B S - 468-449 (23S) 
C S - 301-282 (ITS) 
D ~P - 669-650(23S) 
E S -- 423-404 (23S) 
F S + 404-423 (23S) 
G P + 282-301 (ITS) 
H P + 381-400 (23S) 
I P + 536-552 (23S) 
J P - 552-536(23S) 
K P -- 714-696 (23S) 
G GAGACCCGG CCACTG1-FAT 
GAGGCATATCGCAGCCCGTC 
G GAGCCG GTTGAAAl-rGATA 
CACCTGACG GI-IATCACACG 




G GTACACCACAGTTTTTGTG  
CCACAAAAACTGTGGTGTACC 
CCGTCACAGGCTGAACAG 
The suffix S in the primer number indicates a sequencing primer, P indicates probe or PCR primer. The G. vaginalis pecific base 
sequences were deduced by comparisons with other known ITS and 23S sequences and the location of the primers in either the ITS or 
the 23S sequence is indicated between brackets. 
Table 3. Comparison of biochemical and fatty acid 
profilihg and PCR mediated strain identification for G. 
vaginalis 
code CCUG fatty ID32 PCR 
nr. nr. acid strep 
1 26756 + + - 
2 4121 + + + 
3 26920 + + + 
4 I00~9 + + + 
5 713~ - - -- 
6 26996 + + + 
7 30840 - + + 
28963 + +. + 
9 26921 + - + 
10 26939 + + + 
11 7751 + - + 
12 27435 + -- ± 
13 11675 - - -- 
Strain 11675 is S. acidominimus. PCR has been performed using 
primer set H/K combined with probe D. "+" indicates identity, 
" - "  non-identity with the expected value for G. vaginalis. 
In order to evaluate the clinical applicability of 
the G. vaginalis test and to establish G. vaginalis 
prevalence in women living in the area around or 
within Delft (the Netherlands), several groups of fe- 
males were selected. Cervical smears were collected 
from 52 females attending the gynaecology de- 
partment for either cervical cytology screening (n= 
32) or gynaecological problems not related to bac- 
teriological infection (n=20). These patients are con- 
sidered normal controls, since no apparent growth of 
G. vaginalis was observed upon cultivation of the 
cervical smears. No clinical signs of bacterial va- 
ginosis were documented either, thereby cor- 
roborating the apparent absence of cultivable G. 
vaginalis. Smears were also obtained from 11 women 
suffering from clinically confirmed bacterial vaginosis 
(BV). Finally, 20 pregnant females were sampled at 
time of delivery and the body weight of all babies 
was determined, as was duration of gestation. Smears 
were obtained using Ayre spatulas which were im- 
mersed in culture medium and transported to the lab, 
where a DNA isolation was carried out. A 100-p.I 
sample of the smear was incubated with proteinase 
K and Triton-X100 at 37°C for 1 h. After 10min of 
boiling, the material could be used as amplification 
template. 2° DNA was subjected to two PCRs (GJ and 
HK primer combination) and reaction products were 
typed by hybridization with DNA probes. All cervical 
samples displayed normal cytology and no HPV16 
or 18 could be detected by PCR. 2° 
RESULTS 
Sequence analysis 
The nucleotide sequence of a DNA fragment of 855 bp 
was determined (Genbank accession number 
L08167). At the 5' end, 13 bases of the 16S rRNA 
gene were present, whereas the 23S rRNA sequence 
started around position 370. This implies that the 
genuine-ITS sequence comprised approximately 
360bp. Using PC gene software, no tRNA genes 
could be detected within this region. The results of 
the sequence comparisons, leading to design of the 
PCR primers and probes mentioned below are avail- 
able upon request. 
Evaluation of PCR assays 
The selection of G. vaginalis-specific oligonucleotides 
enabled three PCR tests to be performed. Primer G 
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could be combined with primer J, making H the probe 
of choice. Combining primers H and K for PCR makes 
both primers J and D suitable for probe hybridization. 
With primers G and K in the PCR, primers H, J and 
D turn into suitable probes (see also Table 2). The 
results of PCR/probing analyses are summarized in 
Table 1. Although some of the non-Gardnerella or- 
ganisms displayed DNA amplification using the spe- 
cific PCR primers, upon hybridization none of these 
amplimers crosshybridizes with the probe used (see 
also Figure 1 ). Only in case of the G/K PCR some false- 
positives became apparent. Minor crossreactivity was 
observed towards Bifidobacterium bifidum, but major 
specificity problems were encountered when Lacto- 
bacillus acidophilus strains were studied. However, 
the probes (H, J and D) all appear to be useful, be it 
in combination with other PCR assays (G/J and H/K). 
The sensitivity of the assays was in the order of 1 pg 
of G. vaginalis DNA. This should be sufficient for 
clinical use since in BV G. vaginalis is thought to be 
present in large numbers. 
Species typing in relation with biochemical 
characteristics and fatty acid analysis 
Phenotypic analysis of twelve G. vaginalis isolates 
and one isolate of a related species were performed 
by the ID32 strep Microtest and fatty acid analysis. 
Generally, the fatty acid content of G. vaginalis con- 
sisted of 40% palmitate, 33% oleate, 9% myristate, 
8% stereate and 3% palmitoleate. A survey of all 
results obtained is given in Table 3. For two strains 
(numbers 11 and 12) the identification results of the 
biochemical and fatty acid analyses were con- 
tradictory. Fatty acid analysis identified the strain as 
G. vaginalis which was confirmed by a positive PCR 
result. Except for strain 1, all remaining strains that are 
positive in the fatty acid analysis or the biochemical 
typing or both are identified as G. vaginalis by PCR. 
One strain with abberant fatty acid profile and another 
strain with a deviating ID32 strep test were still 
identified as G. vaginalis by PCR (isolates 7 and 
9, respectively). The results for strain 5, negative 
biochemistry and abberant fatty acid profile, are cor- 
robarated by a negative PCR result. 5. acidominimus 
remains negative in the PCR test. 
The identification of G. vaginalis by means of 
phenotypic tests is known to be troublesome and 
fatty acid analysis often does not distinguish between 
closely related organisms, lz However, amoqg this 
limited number of isolates the results of both pheno- 
and genotyping assays show a considerable degree 
of homology. In eight out of 13, all results point in 
the same direction (isolates 2-6, 8, 10 and 13, see 
Table 3). For three strains (numbers 9, 11 and 12 in 
table 3), the ID32 identification is contradictory with 
PCR and fatty acid analysis. In these cases fatty acid 
analysis and PCR identify the organism as G. vaginalis, 
whereas the ID32 test is negative in this respect. For 
one strain (number 7, table 3), fatty acid analysis is 
negative whereas PCR and ID32 strep testing identify 
G. vaginalis. 
Perinatal G. vaginalis infections 
In the randomized group of gynaecological patients 
19 out of 52 women (37%) carried G. vaginalis. Ten 
out of 11 BV patients were positive for G. vaginalis. 
This comprises over 90% of the females in this group. 
Among the pregnant women, nine out of 20 were 
colonized with G. vaginalis (45%). For a survey of 
these data, see Table 4. There appears to be no 
statistically significant difference in prevalence be- 
tween the control group and the group of pregnant 
women. Apparently, pregnancy does not predispose 
to G. vaginalis colonization. Children born from G. 
vaginalis-infected females showed an average weight 
of 3290 g and gestation lasted 39.2 weeks. For chil- 
dren from the non-colonized females the average 
weight was 3360g, duration of gestation was 40-1 
weeks. This does not constitute a statistically sig- 
nificant difference. 
DISCUSSION 
A .sensitive and specific PCR assay has been de- 
veloped for G. vaginalis. DNA sequences within the 
internal transcribed spacer and 23S rRNA region 
appeared to be both species specific and well-enough 
conserved among isolates to allow adequate test de- 
sign. For several other species sequence variation 
has been documented in the ITS region 21 but in G. 
vaginalis, if any variability exists, this does not seem 
to hamper test results. It has to be mentioned that the 
most optimal PCR assay (primers H and K combined 
with probe D) uses sequences from the 23S gene 
exclusively. In this case potential ITS variability is of 
no diagnostic concern. Since the PCR discriminates 
between genuine G. vaginalis and G. vaginalis-like 
organisms this test could provide additional clues 
when identity of a given organism is questionable 
(see Table 3). A recently published study on G. va- 
ginalis-like organisms from the reproductive tract of 
the mare could profit from additional PCR analysis. 22 
G. vaginalis has repeatedly been indicated as an 
organism at least partially responsible for various 
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Fig. 1. (A) Survey of amplimers obtained by PCR mediated amplification of DNA from G. vaginalis, other micro- 
organisms and cervical smears by use of primers H and K (see Table 2 for primer sequences). Note that only when G. 
vaginalis DNA is present, is a fragment of the correct length generated, other template DNAs give rise to unspecifically 
synthesised DNA molecules at best. Lanes marked M contain bacteriophage lambda DNA, digested with the restriction 
enzyme Hindlll, which serves as molecular length marker. The lane numbering corresponds to samples obtained after 
amplification of DNA from the following materials: Top panel, purified DNA from 1. G. vaginalis CCUG 371 7; 2. G. 
vaginalis CCUG 3990; 3. G. vaginalis CCUG 4123; 4. G. vaginalis CCUG 7921; 5. G. vaginalis CCUG 11278A; 6. 
Staphylococcus aureus; 7. G. vaginalis CCUG 28963; 8. G. vaginalis CCUG 30587; 9. G. vaginalis CCUG 30841; 10. 
G. vaginalis CCUG 7154; 11. G. vaginalis CCUG 7712; 12. G. vaginal?s ATCC 14018/11; 13. molecular length marker; 
14. Bifidobacterium breve LMG 13208; 15. Bifidobacterium Iongum LMG 13207; 16. Bifidobacterium magnum LMG 
11590; 17. Bifidobacterium bifidum LMG 13209; 18. Bifidobacterium infantis LMG 13203; Middle panel. DNA from 
cervical smears from women not presenting symptoms (lanes 1 through 8). Lane 9 displays the molecular length marker, 
lanes 10 through 19 harbour amplified DNA from the following Lactobacillus acidophilus strains: 10. 1719/8; 11. 1834; 
12. 1893; 13. 2028; 14. 1997; 15. 1919; 16. 2604/5; 17. 2604/8; 18. 3313/16; 19. 5658/19; Bottom panel, amplimers 
obtained after amplification of 50 ng of purified DNA from the following micro-organisms: 1. Mycoplasma hominis; 2. 
Escherichia coli; 3. Chlamydia trachomatis; 4. Bacillus subtilis; 5. Listeria monocytogenes; 6. Enterococcus sp.; 7. 
molecular length marker; 8. Peptococcus sp.; 9. Streptococcus agalactiae; 10. Salmonella serovar godesberg; 11. 
Salmonella serovar flexneri. Lane 12 contains the results of a negative control amplification. Instead of DNA only water 
was added. (B) Hybridization analysis. DNA from the gels shown in (A) was transferred to nylon and the resulting blot 
was hybridized with probe D (see Table 2). Note that only DNA synthesised with G. vaginalis DNA as template shows 
specific hybridization with the probe (see also Results and Discussion section). 
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Table 4. Detection of Gardnerella vaginalis by PCR in 
cervical smears from diverse groups of women 
Present-. Absent 
Random group (n=52) 19/52 (37%) 33•52 (63%) 
Pregnant women (n=20) 9/20 (45%) 11/20 (55%) 
BV patients (n=11) 10/11 (91%) 1/11 (9%) 
The number of women in each group is indicated by n, 
percentages are given between brackets. BV: bacterial vaginosis. 
genital syndromes both in men 23 and women. 24 Mul- 
tiple studies on neonatal infection have been per- 
formed. 2s'26 In our patient population, the G. vaginalis 
prevalence in non-symptomatic, non-pregnant fe- 
males is 36% (19/52 individuals), whereas in pregnant 
females this percentage amounts to 45%. These per- 
centages exceed the number of carriers (6%) as re- 
ported before. 27 However, this latter prevalence was 
determined by cultivation assays and it may be as- 
sumed that the sensitivity of PCR is superior to that 
of cultivation. 
G. vaginalis may be involved in prematurity or 
growth retardation of the newborn infant. In two 
previous large studies on the effect of G. vaginalis 
infection on preterm birth, percentages of col- 
onization are low, but both these studies indicate 
significant differences in degree of colonization in 
women either giving preterm birth (12% and 23%, 
respectively) or giving birth at term (6% and 15%, 
respectively). 28'29 These results are again based on 
cultivation assays. Data from preliminary studies using 
PCR as the diagnostic instrument are not yet sufficient 
to confirm or reject these data (work in progress). It 
is also reassuring to note that the G. vaginalis in- 
cidence in patients suffering from bacterial vaginosis 
is in the order of 90%. Percentages as high as 64-79% 
and diagnosed by cultivation have been reported2 °
More extensive studies employing PCR diagnosis 
of G. vaginalis and other BV related micro-organisms 
are required, whereas also quantification of the actual 
number of G. vaginalis bacteria present may have 
clinical implications21 A technical problem is posed 
by the fact that PCR, fatty acid analysis and bio- 
chemical determination sometimes show con- 
tradictory results. If the clinical relevance of G. 
vaginalis infection is to be established, additional 
evaluation of diagnostic procedures is still required. 
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